Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Lightcone Capital, founded by Emil Kendziorra and Mirela Mus, operates from Berlin, Germany. Established as a venture studio, the firm focuses on building companies that generate cash flow while pursuing high-impact moonshot projects, particularly in the longevity sector. The organization has a compact team of three employees and has been instrumental in founding over 100 companies, including eight moonshot projects. This unique model emphasizes rapid growth and profitability to support their ambitious initiatives.
Lightcone Capital's operational approach diverges from traditional venture capital, as it rarely invests in existing companies but instead focuses on founding and growing new ventures. The firm has a strong emphasis on the longevity sector, which is reflected in its portfolio and investment strategy. The organization has established a notable presence in Europe, particularly in Germany, and continues to seek innovative opportunities that align with its mission.
Lightcone Capital invests in both cash-flow generating companies and moonshot projects, primarily focusing on the longevity sector. Their investment strategy is sector agnostic, allowing them to explore various opportunities, but they predominantly target longevity, biotech, and healthcare. The firm typically seeks first or second-time founders to lead new ventures, emphasizing the importance of rapid growth and profitability to support their moonshot initiatives.
The organization engages in funding stages ranging from friends and family to growth equity, reflecting its flexible approach to investment. Lightcone Capital's thesis revolves around building cash-flow generating companies that can subsidize high-impact projects, particularly in the longevity space. This dual focus allows them to balance immediate financial returns with long-term scientific advancements.
Lightcone Capital has a diverse portfolio of notable companies, including:
These companies reflect Lightcone Capital's commitment to supporting innovative ventures that align with their focus on longevity and healthcare. The firm has been involved in founding over 100 companies, showcasing its active role in the startup ecosystem.
Emil Kendziorra - Co-founder. Emil holds an M.D. and graduated summa cum laude from the University of Göttingen. He has a background in cancer research and is a serial entrepreneur with two verified exits: Medlanes, acquired by ZAVA, and onFeedback, acquired by QuestionPro. Emil currently serves as the CEO of Tomorrow Bio and is the President of the European Biostasis Foundation.
Mirela Mus - Co-founder. Mirela is a computer scientist with an MBA and has held leadership roles in various startups. She founded Product People, a profitable consultancy specializing in product management in Germany. Her expertise lies in guiding startups through their growth phases.
To pitch to Lightcone Capital, founders should use the email address berlin@lightcone.capital. It is important to include a comprehensive business plan, financial projections, and a clear explanation of how the startup aligns with Lightcone's focus on longevity and cash-flow generation. The firm values detailed presentations that outline the potential for rapid growth and profitability.
Response times may vary, but founders should expect a thorough review process. Warm introductions are beneficial, but not mandatory, for those looking to connect with the firm.
Lightcone Capital runs a program focused on building cash-flow generating companies that can support high-impact moonshot projects. This program is designed to identify and nurture innovative startups in the longevity sector, providing them with the necessary resources and guidance to succeed.
Eligibility for participation in this program typically includes being a first or second-time founder with a strong business idea that aligns with Lightcone's investment focus. Interested founders can apply by reaching out via the firm's contact email.
In recent months, Lightcone Capital has continued to expand its portfolio, actively founding new companies in the longevity sector. Notable developments include the ongoing growth of Tomorrow Bio, where Emil Kendziorra serves as CEO, and the successful operations of Medlanes, which has gained traction in the digital healthcare space.
Lightcone Capital remains engaged in the startup ecosystem, seeking innovative ventures that align with its mission. The firm is also involved in discussions and presentations at industry conferences, further establishing its presence in the longevity and biotech sectors.
What are Lightcone Capital's investment criteria?
Lightcone Capital primarily invests in cash-flow generating companies and moonshot projects, focusing on the longevity sector. They look for first or second-time founders and prioritize rapid growth and profitability.
How can I apply or pitch to Lightcone Capital?
Founders can pitch their ideas by reaching out via email at berlin@lightcone.capital. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes Lightcone Capital different from traditional VCs?
Lightcone Capital operates more as a venture studio than a traditional VC. They focus on founding companies and providing operational management rather than merely investing in existing startups.
What is the geographic scope of Lightcone Capital's investments?
The firm primarily operates in Europe, with a specific focus on Germany, where it is based.
What is the typical check size for investments?
While specific check sizes are not disclosed, Lightcone Capital engages in funding stages from friends and family to growth equity, indicating a flexible approach to investment amounts.
What kind of post-investment involvement does Lightcone Capital have?
Lightcone Capital provides operational management and strategic guidance to its portfolio companies, leveraging its expertise in the longevity sector to support growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.